GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 5.548
NA - Nord America 3.002
AS - Asia 2.850
SA - Sud America 402
Continente sconosciuto - Info sul continente non disponibili 274
AF - Africa 32
OC - Oceania 1
Totale 12.109
Nazione #
RU - Federazione Russa 4.010
US - Stati Uniti d'America 2.920
SG - Singapore 989
CN - Cina 539
IT - Italia 498
IE - Irlanda 480
HK - Hong Kong 468
BR - Brasile 334
VN - Vietnam 294
KR - Corea 175
GB - Regno Unito 133
DE - Germania 114
JP - Giappone 112
IN - India 89
FR - Francia 66
TR - Turchia 64
BD - Bangladesh 46
UA - Ucraina 44
CA - Canada 41
GR - Grecia 41
FI - Finlandia 37
MX - Messico 24
SE - Svezia 24
AT - Austria 21
AR - Argentina 20
NL - Olanda 19
ES - Italia 15
ZA - Sudafrica 15
IQ - Iraq 13
EC - Ecuador 11
PL - Polonia 10
CL - Cile 9
CH - Svizzera 7
CO - Colombia 7
PE - Perù 7
PK - Pakistan 7
VE - Venezuela 7
NO - Norvegia 6
SA - Arabia Saudita 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
MA - Marocco 5
NP - Nepal 5
AZ - Azerbaigian 4
BO - Bolivia 4
EG - Egitto 4
IL - Israele 4
MY - Malesia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
ET - Etiopia 3
JM - Giamaica 3
PT - Portogallo 3
PY - Paraguay 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
EU - Europa 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 11.837
Città #
Moscow 1.445
San Jose 597
Dublin 471
Singapore 462
Hong Kong 457
Santa Clara 410
Ashburn 219
Seoul 172
Chandler 155
Ho Chi Minh City 114
Beijing 109
Naples 103
Hefei 99
Jacksonville 98
Council Bluffs 95
Aversa 81
Los Angeles 67
Hanoi 66
Dallas 64
New York 63
Princeton 58
Roxbury 58
Istanbul 57
Bengaluru 49
Cambridge 43
The Dalles 30
Caserta 28
Bremen 26
São Paulo 26
Orem 25
Memphis 24
Munich 24
Milan 23
Da Nang 21
Atlanta 19
Wilmington 19
Des Moines 18
Afragola 17
Medford 17
Rome 17
San Francisco 16
Helsinki 14
Boardman 13
Frankfurt am Main 13
Chicago 12
Johannesburg 12
Nuremberg 12
Toronto 11
Brooklyn 10
Falkenstein 10
Montreal 10
Turku 10
Viterbo 10
Denver 9
Lappeenranta 9
Phoenix 9
Tokyo 9
Warsaw 9
Haiphong 8
London 8
Manchester 8
Mexico City 8
Rio de Janeiro 8
Vienna 8
Woodbridge 8
Baghdad 7
Brasília 7
Stockholm 7
Changsha 6
Chennai 6
Hải Dương 6
Norwalk 6
Belo Horizonte 5
Giugliano in Campania 5
Hamburg 5
Kyiv 5
Madrid 5
Manaus 5
Marzano di Nola 5
Pune 5
Ribeirão Preto 5
Shanghai 5
Tulsa 5
Bergen 4
Boston 4
Brussels 4
Buffalo 4
Bến Tre 4
Canoas 4
Etobicoke 4
Guarulhos 4
Guayaquil 4
Hillsboro 4
Houston 4
Jinan 4
Kochi 4
Lima region 4
Nanjing 4
Nova Friburgo 4
Palo Alto 4
Totale 6.368
Nome #
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 290
EPA Guidance on treatment of cognitive impairment in schizophrenia 191
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 191
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 181
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 174
EPA guidance on assessment of negative symptoms in schizophrenia 174
Aetiopathological mechanisms of negative symptoms in schizophrenia 168
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 161
'Precision psychiatry' needs to become part of 'personalized psychiatry' 160
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 155
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 154
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 154
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 154
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 153
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 152
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 149
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 146
Accuracy of self-assessment of real-life functioning in schizophrenia 142
EPA guidance on treatment of negative symptoms in schizophrenia 140
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 140
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 139
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 138
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 138
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity 138
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 137
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 137
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 136
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 136
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 136
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 132
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 131
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 129
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 129
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 129
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 126
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 125
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses 123
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 123
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 123
Association of functional genetic variation in PP2A with prefrontal working memory processing 122
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 120
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 120
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review 118
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 118
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 117
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 117
Neurobiology of Schizophrenia: Electrophysiological indices 117
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 116
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 115
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia 113
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia 113
VTA-insula connectivity and avolition in subjects with schizophrenia 111
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 111
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 110
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 109
Neuroimaging: Diagnostic boundaries and biomarkers 109
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 108
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 107
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 107
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 107
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 106
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 105
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 105
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 105
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 105
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 104
EPA guidance on assessment of cognitive impairment in schizophrenia 103
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 101
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 100
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 100
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 99
Relationship between MMN and real-life functioning in subjects with schizophrenia 98
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 97
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 96
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 96
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 94
MMN impairment in subjects with schizophrenia among different stages of disease 93
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 93
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 93
Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania 92
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 92
Electrophysiological correlates of negative symptom domains in schizophrenia 92
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 92
Laryngopharyngeal reflux and psychological distress: a vicious cycle worth investigating 90
P3a and real-life functioning in a sample of chronic schizophrenia subjects 88
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 88
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 87
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 87
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 87
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 86
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial 85
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 85
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia 84
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 82
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 82
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 82
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 80
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 79
Worldwide initiatives aimed to train professionals in the use of the ICD-11 79
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 77
Totale 11.908
Categoria #
all - tutte 41.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022414 0 0 9 12 106 16 14 8 17 71 38 123
2022/2023791 72 23 25 40 66 53 10 28 417 10 19 28
2023/2024468 25 24 37 39 134 46 9 10 7 9 32 96
2024/20251.899 7 19 11 142 263 265 260 147 256 263 136 130
2025/20267.393 343 485 331 302 609 3.749 446 304 241 297 201 85
2026/2027619 63 380 176 0 0 0 0 0 0 0 0 0
Totale 12.109